April 4, 2019 — iCAD announced it will present its latest artificial intelligence (AI) software solution for digital breast tomosynthesis (DBT), ProFound AI, as well as its PowerLook Density Assessment software, during the 2019 Society of Breast Imaging (SBI) Annual Symposium, April 4-7, in Hollywood, Fla.
ProFound AI is a high-performance, deep-learning, cancer detection and workflow solution for DBT. The technology delivers critical benefits to radiologists, their facilities and patients through the improvement of cancer detection rates by an average of 8 percent and a reduction in the rate of unnecessary patient recalls by an average of 7 percent. It is designed to detect malignant soft-tissue densities and calcifications, and provides radiologists with the certainty of finding lesion and case scores. Since its U.S. launch in December 2018, ProFound AI has been adopted by a significant number of high-profile hospitals and imaging centers in all major geographic areas of the country, according to iCAD.
“Enhanced breast cancer detection remains a critical healthcare initiative, as evidenced by the recently proposed regulations from the U.S. Food and Drug Administration (FDA) requiring breast density reporting,” said Stacey Stevens, president of iCAD. “The new proposed regulations would enhance FDA’s ability to enforce mammography facilities’ compliance with breast density reporting standards.” She added that PowerLook Density Assessment is designed to standardize the assessment of fibroglandular breast density in 2-D and 3-D mammography, which could play an important role in healthcare facilities’ ability to adhere to the new proposed FDA regulations.
For more information: www.icadmed.com
September 30, 2026 
